Grant
Title | Due Date | Maximum Award Amount Sort descending | Description |
---|---|---|---|
Modoc County APCD FARMER Program | No Due Date Given | Varies | FARMER program is to help California's agricultural industry to reduce emissions to help meet federal ozone and particulate matter air quality standards. Applicants can apply to Off-Road Agricultural Equipment, On-Road Agricultural Truck, Zero-Emission Agricultural UTV, and Infrastructure. Applications can be delivered to the following address: 202 W. 4th St Alturas, CA 96101 or P.O. Box 222 Tulelake, CA 96134. Any questions please contact Jennifer White email: jenniferwhite@co.modoc.ca.us Cell: (541) 740-4555. http://www.co.modoc.ca.us/departments/agricultural/air_pollution_control_2.php |
Northern Sierra AQMD Wood Stove Change-Out Program | No Due Date Given | Varies | The Air District is offering a change-out program to qualified homeowners within the Greater Portola PM2.5 Non-attainment Area in Plumas County, California for replacement of non-EPA certified wood stoves with new, efficient, cleaner burning EPA certified devices. This program is funded by the U.S. EPA’s 2015 Targeted Air Shed Grant Program, the District’s AB2766 program and other agencies. This 5-year voluntary program is only available to residents within the non-attainment area. https://myairdistrict.com/index.php/grants-incentives/portola-woodstove-change-out-program/ |
Ag Pump Program | No Due Date Given | Varies | This program provides incentives for engine replacement (repower) of engines/motors used to power agricultural irrigation pumps. Funds are provided on a first come, first serve basis and applicants must obtain approval and have a signed, executed contract from the SJVAPCD prior to purchase of new equipment. Any equipment purchased prior to contract execution is ineligible as this is not a rebate program. https://valleyair.org/grants/agpump.htm |
FY 2021 Competitive Funding Opportunity: Low or No Emission Vehicle Program | Varies | The Federal Transit Administration (FTA) announces the opportunity to apply for $180 million in competitive grants under the fiscal year (FY) 2021 Low or No Emission Grant Program (Low-No Program) (Federal Assistance Listing: 20.526). As required by Federal public transportation law, funds will be awarded competitively for the purchase or lease of low or no emission vehicles that use advanced technologies for transit revenue operations, including related equipment or facilities. Additionally, recipients are permitted to use up to 0.5 percent of their requested grant award for workforce development activities eligible under Federal public transportation law (49 U.S.C. 5314(b)) and an additional 0.5 percent for costs associated with training at the National Transit Institute. Projects may include costs incidental to the acquisition of buses or to the construction of facilities, such as the costs of related workforce development and training activities, and project administration expenses. https://www.grants.gov/web/grants/view-opportunity.html?oppId=331458 |
|
Understanding the Rules of Life: Emergent Networks | Varies | In 2016, the National Science Foundation (NSF) unveiled a set of "Big Ideas," 10 bold, long-term research and process ideas that identify areas for future investment at the frontiers of science and engineering (see https://www.nsf.gov/news/special_reports/big_ideas/index.jsp). The Big Ideas represent unique opportunities to position our Nation at the cutting edge of global science and engineering by bringing together diverse disciplinary perspectives to support convergence research. As such, when responding to this solicitation, even though proposals must be submitted to the Division of Emerging Frontiers in the Directorate for Biological Sciences (BIO/EF), once received, the proposals will be managed by a cross-disciplinary team of NSF Program Directors. TheUnderstanding the Rules of Life: Predicting Phenotype"Big Idea" is based on developing a predictive understanding of how key properties of living systems emerge from interactions of factors such as genomes, phenotypes, and evolving environments.Ideally, the predictive capability of the Rules of Life explored byprojects supported by the programwill enable us to address some of the greatest challenges we currently face in understanding the living world.This Understanding the Rules of Life: Emergent Networks (URoL:EN) solicitation is a cross-directorate program of NSF that aims to develop a predictive understanding of how key properties of living systems emerge from interactions of factors such as genomes, phenotypes, and environments and how emerging networks of organismal, natural, social, and/orhuman-engineered systems respond to or influence evolving environments.Successful projects of the URoL:EN program are expected to use convergent approaches that explore emergent network properties of living systems across various levels of organizational scale and, ultimately, to contribute to understanding the rules of life through new theories and reliable predictions about the impact of specific environmental changes on behaviors of complex living systems, or engineerable interventions and technologies based on a rule of life to address associated outcomes for societal benefit. Projects that advance all of the different fields of science represented in the project and that represent different NSF Directorates are strongly encouraged. Using such convergent approaches, proposals must: Identify a rule(s) of life around which the proposed research is oriented or to which the research is applied. Include a compelling convergent research plan with deep integration across disciplines. Involve a basic, or fundamental, research approach to investigate a new understanding of emergent networks of interactions between organisms and Earth, human, natural, and/or human-engineered systems in evolving environments. The convergent scope of URoL:EN projects also provides unique STEM education and outreach possibilities to train the next generation of scientists in a diversity of approaches and to engage society more generally. Hence, the URoL:EN program encourages research projects that integrate training and outreach activities in their research plan, provide convergent training opportunities for researchers and students, develop novel teaching modules, and broaden participation of under-represented groups in science. The URoL:EN Program will support projects with a total budget of up to $3,000,000 and an award duration of up to 5 years. https://www.grants.gov/web/grants/view-opportunity.html?oppId=336816 |
|
ROSES 2022: ECOSTRESS Science and Applications Team | Varies | Please note that this program requests optional Notices of Intent, which are due via NSPIRES by May 4, 2022. See the full posting on NSPIRES for details. Proposers must retrieve the instructions document (zip file) associated with the application package for this opportunity as there is at least one required form that must be attached to the submitted proposal package. The National Aeronautics and Space Administration (NASA) Science Mission Directorate (SMD) released its annual omnibus Research Announcement (NRA), Research Opportunities in Space and Earth Sciences (ROSES) – 2022 (OMB Approval Number 2700-0092, CFDA Number 43.001) on February 14, 2022. In this case "omnibus" means that this NRA has many individual program elements, each with its own due dates and topics. All together these cover the wide range of basic and applied supporting research and technology in space and Earth sciences supported by SMD. Awards will be made as grants, cooperative agreements, contracts, and inter- or intra-agency transfers, depending on the nature of the work proposed, the proposing organization, and/or program requirements. However, most extramural research awards deriving from ROSES will be grants, and many program elements of ROSES specifically exclude contracts, because contracts would not be appropriate for the nature of the work solicited. The typical period of performance for an award is three years, but some programs may allow up to five years and others specify shorter periods. In most cases, organizations of every type, Government and private, for profit and not-for-profit, domestic and foreign (with some caveats), may submit proposals without restriction on teaming arrangements. Tables listing the program elements and due dates, the full text of the ROSES-2022 solicitation, and the "Summary of Solicitation" as a stand-alone document, may all be found NSPIRES at http://solicitation.nasaprs.com/ROSES2022. This synopsis is associated with one of the individual program elements within ROSES, but this is a generic summary that is posted for all ROSES elements. For specific information on this particular program element download and read the PDF of the text of this program element by going to Tables 2 or 3 of this NRA at http://solicitation.nasaprs.com/ROSES2022table2 and http://solicitation.nasaprs.com/ROSES2022table3, respectively, click the title of the program element of interest, a hypertext link will take you to a page for that particular program element. On that page, on the right side under "Announcement Documents" the link on the bottom will be to the PDF of the text of the call for proposals. For example, if one were interested in The Lunar Data Analysis Program (NNH22ZDA001N-LDAP) one would follow the link to the NSPIRES page for that program element and then to read the text of the call one would click on “C.8 Lunar Data Analysis (.PDF)” to download the text of the call. If one wanted to set it into the context of the goals, objectives and know the default rules for all elements within Appendix C, the planetary science division, one might download and read “C.1 Planetary Science Research Program Overview (.PDF)” from that same page. While the letters and numbers are different for each element within ROSES (A.12, B.7, etc.) the basic configuration is always the same, e.g., the letter indicates the Science Division (A is Earth Science, B is Heliophysics etc.) and whatever the letter, #1 is always the division overview. Frequently asked questions for ROSES are posted at http://science.nasa.gov/researchers/sara/faqs. Questions concerning general ROSES-2022 policies and procedures may be directed to Max Bernstein, Lead for Research, Science Mission Directorate, at sara@nasa.gov, but technical questions concerning specific program elements should be directed to the point(s) of contact for that particular element, who may be found either at the end of the individual program element in the summary table of key information or on the web list of topics and points of contact at: http://science.nasa.gov/researchers/sara/program-officers-list. Not all program elements are known at the time of the release of ROSES. To be informed of new program elements or amendments to this NRA, proposers may subscribe to: (1) The SMD mailing lists (by logging in at http://nspires.nasaprs.com and checking the appropriate boxes under "Account Management" and "Email Subscriptions"), (2) The ROSES-2022 RSS feed for amendments, clarifications, and corrections to at http://science.nasa.gov/researchers/sara/grant-solicitations/ROSES-2022, and (3) The ROSES-2022 due date Google calendars (one for each science division). Instructions are at https://science.nasa.gov/researchers/sara/library-and-useful-links (link from the words due date calendar). https://www.grants.gov/web/grants/view-opportunity.html?oppId=338012 |
|
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed) | Varies | The overall goal of the Fogarty International Center (FIC) HIV Research Training Program is to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research on the evolving HIV epidemic in their countries.This FOA encourages collaborative applications from U.S. and LMIC institutions to support training to achieve technical, administration and financial management expertise required for one of the six research infrastructure functions considered critical to a successful high quality research environment:Research administration and management;Research integrity oversight;Ethical review of research for the protection of human subjects;Laboratory animal welfare oversightHealth sciences library and information services; andInformation and communications technology systems (ICT) for researchResearch infrastructure training programs will maximize previous investments and further strengthen the LMIC institution's research capabilities, and provide more accessible research infrastructure training opportunities to others in their own country and in other LMICs. https://www.grants.gov/web/grants/view-opportunity.html?oppId=339677 |
|
Fiscal Year (FY) 2022 Emergency Operations Center (EOC) Grant Program- Region 2 | Varies | The Fiscal Year (FY) 2022 Emergency Operations Center (EOC) Grant Program is intended to improve emergency management and preparedness capabilities by supporting flexible, sustainable, secure, strategically located, and fully interoperable EOCs with a focus on addressing identified deficiencies and needs. Fully capable emergency operations facilities at the state and local levels are an essential element of a comprehensive national emergency management system and are necessary to ensure continuity of operations and continuity of government in major disasters or emergencies caused by any hazard. Among the five basic homeland security missions noted in the DHS Strategic Plan, the EOC Grant Program supports the goal to Strengthen National Preparedness and Resilience. The 2022-2026 FEMA Strategic Plan outlines three bold, ambitious goals in order to position FEMA to address the increasing range and complexity of disasters, support the diversity of communities we serve, and complement the nation's growing expectations of the emergency management community. The EOC Grant Program supports Goal 3: Promote and Sustain a Ready FEMA and a Prepared Nation. https://www.grants.gov/web/grants/view-opportunity.html?oppId=340324 |
|
Fiscal Year (FY) 2022 National Dam Safety Program (NDSP) - Region 7 | Varies | The National Dam Safety Program's mission is to reduce risks to lives, property, and the environment from dam failure by guiding public policy and leveraging industry best practices across the dam safety community. The National Dam Safety Program supports Goal 2: Lead Whole Community in Climate Resilience, Objective 2.3, Empower Risk-Informed Decision Making, of the 2022-2026 FEMA Strategic Plan. ObjectivesThe objectives of the Program are to:- Ensure that new and existing dams are safe through the development of technologically and economically feasible programs and procedures for national dam safety hazard reduction;- Encourage acceptable engineering policies and procedures to be used for dam site investigation, design, construction, operation, maintenance, and emergency preparedness;- Encourage the establishment and implementation of effective dam safety programs in each state based on state standards;- Develop and implement a comprehensive dam safety hazard education and public awareness initiative to assist in preparing for, mitigating, responding to, and recovering from dam incidents;- Develop mechanisms with which to provide Federal technical assistance for dam safety to non-Federal dam safety practitioners; and- Develop technical assistance materials, seminars, and guidelines to improve security for dams in the United States. https://www.grants.gov/web/grants/view-opportunity.html?oppId=340406 |
|
DoD Military Burn, Technology/Therapeutic Development Award | Varies | The MBRP Technology/Therapeutic Development Award is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical application that address one or more of the critical gaps included in the FY22 MBRP TTDA Focus Areas. Products under development must be relevant to military application and address the needs of military Service Members, Veterans, and/or beneficiaries.The product(s) to be developed may be a tangible item such as a pharmacologic agent (including, but not limited to, drugs or biologics); or device-focused. Knowledge products may be considered, provided that the knowledge is applicable to a technology or therapeutic under development. (A “knowledge product” is a non-materiel product that addresses an identified need in one or more of the FY22 MBRP TTDA Focus Areas, is based on current evidence and research, aims to transition into medical practice, training, tools, or to support materiel solutions [systems to develop, acquire, provide, and sustain medical solutions and capabilities], and educates or impacts behavior throughout the continuum of care, including primary prevention of negative outcomes.) The Principal Investigator (PI) must provide a transition plan (including potential funding and resources; see Attachment 7: Transition Plan and Regulatory Strategy) showing how the product will progress to the next level of development (e.g., clinical trials, delivery to the military or civilian market) after the completion of the MBRP award. At the time of pre-application submission the proposed product must be at a minimum technology readiness level (TRL) or knowledge readiness level (KRL) of 3 (Appendix 2).Proof-of-concept and prototype/preliminary version of the proposed product demonstrating the potential utility of the proposed product must be established at the time of pre-application submission. Applications must include relevant data that support the rationale for the proposed study. These data may be unpublished and/or from the published literature.This award mechanism is intended to facilitate progression of research that is supported by significant preliminary data but has not yet advanced to the level of clinical use. Examples of the types of research that may be supported include, but are not limited to:• Testing new therapeutic or technologic modalities (ex: agents, delivery systems, chemical modification of lead compounds, device testing and/or validation) using established or validated preclinical systems• Designing pilot or full-scale Good Manufacturing Practice (GMP) production of therapeutics and/or technologies for use in advanced preclinical studies• Developing pharmacologic agents through absorption, distribution, metabolism, excretion, and toxicity studies• Investigational New Drug (IND) or Investigational Device Exemption (IDE) enabling studiesThe types of awards made under the program announcement will be assistance agreements. An assistance agreement is appropriate when the federal government transfers a “thing of value” to a “state, local government,” or “other recipient” to carry out a public purpose of support or stimulation authorized by a law of the United States instead of acquiring property or service for the direct benefit and use of the U.S. government. An assistance agreement can take the form of a grant or cooperative agreement. The level of involvement on the part of the Department of Defense (DOD) during project performance is the key factor in determining whether to award a grant or cooperative agreement. If “no substantial involvement” on the part of the funding agency is anticipated, a grant award will be made (31 USC 6304). Conversely, if substantial involvement on the part of the funding agency is anticipated, a cooperative agreement will be made (31 USC 6305), and the award will identify the specific substantial involvement. Substantial involvement may include, but is not limited to, collaboration, participation, or intervention in the research to be performed under the award. The award type, along with the start date, will be determined during the negotiation process.The anticipated total costs budgeted for the entire period of performance for an FY22 MBRP TTDA Award will not exceed $2.21M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards will be made no later than September 30, 2023. For additional information refer to Section II.F.1, Federal Award Notices.The CDMRP expects to allot approximately $4.42M to fund approximately two Technology/ Therapeutic Development Award applications. Funding of applications received is contingent upon the availability of federal funds for this program as well as the number of applications received, the quality and merit of the applications as evaluated by scientific and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY22 funding opportunity will be funded with FY22 funds, which will expire for use on September 30, 2028.Impact: The overall impact of the proposed product is a key component of this award mechanism. The applicability to one of the FY22 MBRP Focus Areas should be clearly described. Investigators must describe the potential impact of the research, both short-term and long-term, on the lives of burn-injured individuals. High-impact research will, if successful, lead to the development and translation of therapeutic or technologic advances for clinical application in the care of burn-injured casualties, such as prevention, detection, diagnosis, treatment, or standards of care, and promoting positive long-term outcomes for military health and medicine, as well as the general public.Relevance to Military Health: Relevance to the healthcare needs of military Service Members, Veterans, military beneficiaries, and/or the American public is a key feature of this award. Investigators are encouraged to consider the following characteristics as examples of how a project may demonstrate relevance to military health:• Explanation of how the project addresses an aspect of burn injuries relevant to the military• Description of how the therapy, technology, or knowledge gained from the proposed research could be implemented to address a military needUse of DOD or Department of Veterans Affairs (VA) Resources: If the proposed research involves access to active-duty military or VA patient populations and/or DOD or VA resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research. Refer to Section II.D.2.b.ii, Full Application Submission Components, for detailed information. Refer to the General Application Instructions, Appendix 1, for additional information. Applicants are encouraged to integrate and/or align their research projects with DOD and/or VA research laboratories and programs. Collaboration with DOD or VA investigators is also encouraged. A list of websites that may be useful in identifying additional information about ongoing DOD and VA areas of research interest or potential opportunities for collaboration can be found in Appendix 3.Clinical trials and clinical research studies are not permitted under this award mechanism. Projects involving the use of human anatomical specimens are permitted, provided that the use of such specimens is necessary for device validation, or in vitro or ex vivo studies. Applicants proposing clinical research should consider submitting to the FY22 MBRP Clinical Translational Research Award mechanism.A clinical trial is defined as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Clinical research is defined as: (1) Patient-oriented research. Research conducted with human subjects (or on material of human origin such as tissues, specimens, and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. Excluded from this definition are in vitro studies that utilize human tissues that cannot be linked to a living individual. Patient-oriented research includes: (a) mechanisms of human disease, (b) therapeutic interventions, (c) clinical trials, and (d) development of new technologies. (2) Epidemiologic and behavioral studies. (3) Outcomes research and health services research. Note: Studies that meet the requirements for Institutional Review Board (IRB) Exemption 4 are not considered CDMRP-defined clinical research. IRB Exemption 4 refers to research involving the collection or study of existing de-identified specimens or data, if these sources are publicly available.Rigor of Experimental Design: All projects should adhere to accepted standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. Core standards are described in Landis, S.C., et al., A call for transparent reporting to optimize the predictive value of preclinical research, Nature 2012, 490:187-191 (https://www.nature.com/articles/nature11556). While these standards were written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in research and should be applied consistently across translational studies. Projects that include research on animal models are required to submit Attachment 8, Animal Research Plan, as part of the proposal/ application package to describe how these standards will be addressed. Applicants should consult the Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines 2.0 to ensure relevant aspects of rigorous animal research are adequately planned for and, ultimately, reported. The ARRIVE guidelines 2.0 can be found at https://arriveguidelines.org/arrive-guidelines.Research Involving Human Anatomical Substances, Human Subjects, or Human Cadavers: All DOD-funded research involving new and ongoing research with human anatomical substances, human subjects, or human cadavers must be reviewed and approved by the USAMRDC Office of Research Protections (ORP), Human Research Protection Office (HRPO), prior to research implementation. This administrative review requirement is in addition to the local IRB or Ethics Committee (EC) review. Local IRB/EC approval at the time of submission is not required. Allow up to 3 months to complete the HRPO regulatory review and approval process following submission of all required and complete documents to the HRPO. Refer to the General Application Instructions, Appendix 1, and the Human Research Protections Office Resources and Overview document available on the electronic Biomedical Research Application Portal (eBRAP) “Funding Opportunities & Forms” web page (https://ebrap.org/eBRAP/public/Program.htm) for additional information.If the proposed research involves more than one institution, a written plan for single IRB review arrangements must be provided at the time of application submission or award negotiation. The lead institution responsible for developing the master protocol and master consent form should be identified and should be the single point of contact for regulatory submissions and requirements.Research Involving Animals: All research funded by the FY22 MBRP TTDA involving new and ongoing research with animals must be reviewed and approved by the USAMRDC ORP Animal Care and Use Review Office (ACURO), in addition to the local Institutional Animal Care and Use Committee (IACUC) of record. IACUC approval at the time of submission is not required. Allow at least 3 to 4 months for ACURO regulatory review and approval processes for animal studies. Refer to the General Application Instructions, Appendix 1, for additional information. https://www.grants.gov/web/grants/view-opportunity.html?oppId=340568 |